Narcolepsy trials in Finland
5 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Not yet taking people in FinlandA Study to Investigate the Effects of Cleminorexton Compared with Placebo in the Treatment of Participants with Central Disorders of Hypersomnolence
- Where
- Tampere
- Age
- 18 years and over
- People
- 168 worldwide
- Run by
- Centessa Pharmaceuticals UK Limited
See details and how to join2026-525961-37-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Helsinki
- Age
- 18 years and over
- People
- 116 worldwide
- Run by
- Alkermes Inc.
See details and how to join2025-524711-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Helsinki
- Age
- 18 years and over
- People
- 115 worldwide
- Run by
- Alkermes Inc.
See details and how to join2025-523911-13-00 - Phase 1Taking peopleA Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy
- Where
- Helsinki, Turku
- Age
- 18 years to 64 years
- People
- 104
- Run by
- H. Lundbeck A/S
See details and how to joinNCT07613710 · EU 2024-511073-29-00 - Phase 2/3Taking peopleA Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
- Where
- Helsinki, Tampere
- Age
- 16 years to 70 years
- People
- 500 worldwide
- Run by
- Takeda
See details and how to joinNCT05816382 · EU 2023-508462-15-00